SEC Filings

Form DEF 14A
IOVANCE BIOTHERAPEUTICS, INC. filed this Form DEF 14A on 04/29/2019
Document Outline
Entire Document (887.9 KB)
Subdocument 1 - DEF 14A - DEF 14A
Page 1 - UNITED STATES
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - Corporate Governance Highlights at a Glance
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - N/A
Page 21 - N/A
Page 22 - Director Compensation Table
Page 23 - THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION
Page 24 - Compensation Policies and Practices at a Glance
Page 25 - What we do not do
Page 26 - N/A
Page 27 - N/A
Page 28 - N/A
Page 29 - N/A
Page 30 - N/A
Page 31 - N/A
Page 32 - N/A
Page 33 - N/A
Page 34 - N/A
Page 35 - N/A
Page 36 - N/A
Page 37 - N/A
Page 38 - Chief Executive Officer Pay Ratio
Page 39 - N/A
Page 40 - N/A
Page 41 - N/A
Page 42 - N/A
Page 43 - N/A
Page 44 - N/A
Page 45 - N/A
Page 46 - N/A
Page 47 - N/A
Page 48 - N/A
Page 49 - N/A
Page 50 - N/A
Page 51 - N/A
Page 52 - N/A
Page 53 - N/A
Page 54 - N/A
Page 55 - N/A
Page 56 - N/A
Page 57 - PROPOSAL NO. 3 - APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION, AS AMENDED, TO INCREA
Page 58 - Reasons for the Authorized Shares Amendment
Page 59 - Potential Effects of Approving the Authorized Shares Amendment
Page 60 - N/A
Page 61 - N/A
Page 62 - APPENDIX A
Page 63 - N/A
Page 64 - N/A